Walgreen Co.

1 / 30
About This Presentation
Title:

Walgreen Co.

Description:

... candy, photofinishing, greeting cards, seasonal items, and convenience ... Third-party payors of prescription drugs are attempting to reduce costs and ... – PowerPoint PPT presentation

Number of Views:154
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Walgreen Co.


1
Walgreen Co.
  • (WAG)
  • Presented April 19, 2007

2
Investment Managers
  • Jessica Boghosian
  • jboghos2_at_uiuc.edu
  • Shengdong Zhu
  • szhu4_at_uiuc.edu

3
Company Overview
  • Incorporated in 1909, headquartered in Deerfield,
    Illinois.
  • Nations largest drugstore based on sales
  • Engaged in the retail sale of prescription and
    non-prescription drugs and general merchandise
    including beauty care, personal care, household
    items, candy, photofinishing, greeting cards,
    seasonal items, and convenience foods.
  • Recorded its 32nd year of consecutive earnings
    and sales growth.
  • During the year, Walgreen Co. had a net increase
    of 476 stores, totaling to 5,461 stores located
    in 47 states and Puerto Rico.

4
Company Overview
  • Success is dependent upon continuously opening
    new Walgreens stores.
  • Walgreen Co. plans to operate more than 7,000
    stores by 2010.
  • Walgreen Co. is in the business of strategically
    locating new stores as well as relocating/closing
    existing stores.

5
New Walgreens Co. Stores
  • Over the past 7 years, Walgreen Co. has opened on
    average 1.28 stores/day.

6
National Store Distribution
  • Walgreen Co. has made it a point to open the most
    stores in the states that are the popular
    locations for aging baby boomers to retire.

Image Walgreen Co. Annual Report 2006
7
Product Class Attribution to Sales
8
Pharmacy Sales
  • Pharmacy sales continue to become a larger
    portion of Walgreens business.
  • Walgreens filled 529 million prescriptions in
    2006, totaling to an increase of 8.1 from the
    2005 fiscal year.
  • Sales trends are expected to continue to grow for
    the following reasons
  • Aging population
  • Introduction of lower priced generics
  • Continued development of innovative drugs

9
Medicare Part D
  • Medicare Part D is a government initiated program
    to subsidize the costs of prescription drugs to
    individuals covered by Medicare. Part D was
    implemented in January of 2006.
  • Walgreens has obtained a larger share of senior
    citizen patients due to this program.
  • 35 of the prescriptions filled under this
    program in the first eight months were new
    customers to Walgreens.

10
New Developments
  • Dial-a-Pharmacist
  • Available in 14 languages, this system allows
    customers to discover where there is a Walgreens
    pharmacist that speaks his or her language.
  • Solar Power Usage
  • 100 stores utilize solar energy, making Walgreens
    the largest retail user of this source of energy.
  • Highway Signs
  • A new federal law allows signs to be placed on
    highways informing drivers of the location of 24
    hour pharmacies. Several have already been
    planted with many more to come.

Source Walgreen Co. Annual Meeting, January 2006
11
Corporate Risk
  • Walgreen Co. faces intense competition with
    local, regional, and national companies, many of
    which are infiltrating Walgreens existing
    markets.
  • Extreme competition can have an adverse affect on
    prices.
  • Third-party payors of prescription drugs are
    attempting to reduce costs and pharmacy
    reimbursement rates.
  • On February 8th, 2006, President Bush signed the
    Deficit Reduction Act of 2005
  • This Act will ultimately reduce Medicaid
    reimbursement rates to retail pharmacies.
  • Further reduction in these rates are foreseeable.

12
RCMP Position
  • Originally owned 1000 shares of WAG, purchases on
    October 6th, 1999 for 25.00/share.
  • On September 20th, 2006, 500 shares were sold _at_
    49.94/share for a realized gain of 12,470.
  • Currently own 500 shares of WAG, trading at
    45.96 as of April 19, 2007 for an unrealized
    gain of 10,480 or 83.84.

13
Role in Portfolio
  • Walgreen Co. currently comprises 7 of our
    portfolio.

14
Correlation Matrix
15
5-Year Growth vs. SP 500
16
Competitors
  • Who
  • CVS/Caremark Corp. (CVS)
  • Rite Aid Corp. (RAD)
  • Why
  • Industry Specific
  • Business Segment Specific (prescription and
    non-prescription drugs and general merchandise)

17
Out-performing Its Competitors
  • Prescription Volume

Source Walgreen Co. Annual Meeting, January 2006
18
Out-performing Its Competitors
  • Earnings per square foot

Source Walgreen Co. Annual Meeting, January 2006
19
1-Year Comparables
20
5-Year Comparables
21
Comparable Analysis
22
Assumptions
  • Organic growth continues to be the primary growth
    vehicle
  • Future growth was estimated assuming to be in
    line with increasing medical costs and increasing
    store numbers.
  • We assume that future growth will continue at a
    13 annual rate but will gradually decrease to 9
    over the next five years and then remain at a 3
    annual growth rate thereafter

23
Discounted Cash Flow Analysis
?
24
Discounted Cash Flow Analysis
  • Since Walgreen Co. is 100 equity financed,
    WACCke.
  • Beta Regression 0.1 vs. Bloomberg .66
  • Average .4

25
Discounted Cash Flow Analysis
26
A Note On Capital Structure
  • Walgreen Co. is an all equity financed firm.
  • The company owns a mere 18 of its store base.
    The other 82 is leased.
  • These leases hold Walgreen Co. responsible for
    26.078 billion, but this obligation is not seen
    on the balance sheet as a liability to the firm.
  • This poses potentially risk to Walgreen Co.
  • Lets call these lease obligations quasi-debt.
  • THEREFORE, it is important to keep in mind this
    accounting structure when valuing WAG.

27
Sensitivity Analysis
Most likely to range from 34.73 to 57.04
28
Portfolio Fit
  • Sharpe Ratio
  • a measure of the mean excess return per unit of
    risk in an investment asset or a trading strategy
  • Including WAG generates a higher Sharpe Ratio

29
RCMP Fall 06 Decision
  • 500 Shares of WAG were sold last semester at
    49.94. Why?
  • Lease Obligations
  • WACC was adjusted upward based on the risk of
    outstanding lease obligations
  • After this adjustment, the company appeared to be
    trading at a significantly inflated price that,
    in the long term, could not be sustained.

30
Recommendation
  • HOLD.
  • Why?
  • Healthy management vision
  • Stable, growing company
  • Solid performer
  • Leader in its class
  • But what about these lease obligations and other
    business risks!?
  • Acknowledge that every company has risk, with
    Wagreen Co. as no exception.
  • We have already taken action as conservative
    investors by selling 500 shares.
Write a Comment
User Comments (0)